TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Biokraft Stockholm AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
10,749
|
12,470
|
12,146 |
Financial expenses |
0
|
51
|
122 |
Earnings before taxes |
2,103
|
2,501
|
1,468 |
EBITDA |
2,002
|
2,552
|
1,734 |
Total assets |
8,141
|
9,515
|
15,628 |
Current assets |
4,888
|
5,879
|
3,893 |
Current liabilities |
4,596
|
5,450
|
3,236 |
Equity capital |
3,545
|
4,065
|
4,570 |
- share capital |
9
|
10
![]() |
10 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
43.5%
|
42.7%
|
29.2% |
Turnover per employee | |||
Profit as a percentage of turnover |
19.6%
|
20.1%
|
12.1% |
Return on assets (ROA) |
25.8%
|
26.8%
|
10.2% |
Current ratio |
106.4%
|
107.9%
|
120.3% |
Return on equity (ROE) |
59.3%
|
61.5%
|
32.1% |
Change turnover |
-711
|
549
|
-355 |
Change turnover % |
-6%
|
5%
|
-3% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.